The development, validity, and reliability of the Researcher Investment Tool.

IF 2 Q3 MEDICINE, RESEARCH & EXPERIMENTAL
Journal of Clinical and Translational Science Pub Date : 2025-08-11 eCollection Date: 2025-01-01 DOI:10.1017/cts.2024.673
Brenda M Joly, Carolyn Gray, Kassandra Cousineau, Karen Pearson, Valerie S Harder
{"title":"The development, validity, and reliability of the Researcher Investment Tool.","authors":"Brenda M Joly, Carolyn Gray, Kassandra Cousineau, Karen Pearson, Valerie S Harder","doi":"10.1017/cts.2024.673","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Over the last two decades, there have been significant investments designed to advance clinical and translational research (CTR) with an emphasis on supporting early career investigators and building a cadre of skilled researchers. Despite the investments, there are no comprehensive measurement tools to track individual-level progress along the research continuum as supports are put in place.</p><p><strong>Objective: </strong>The Researcher Investment Tool (RIT) is a novel tool that was created to provide a consistent approach for measuring individual-level changes in the research career trajectory of investigators receiving support from CTR programs.</p><p><strong>Methods: </strong>The RIT is a 90-item questionnaire, with eight domains and four sub-domains, designed to measure a researcher's experiences and perceptions. Several rounds of testing were conducted to assess the tool's face and content validity as well as the internal consistency and test-retest reliability.</p><p><strong>Results: </strong>Psychometric testing revealed strong content validity and good internal consistency with Cronbach's alpha coefficients ranging from 0.85 to 0.97 across all domains. Test-retest reliability results also revealed stability in the domain measures over time with Pearson's correlation coefficients ranging from 0.70 to 0.98 for all but one domain (.53).</p><p><strong>Conclusions: </strong>This novel RIT may be useful to evaluators when measuring the impact of investments designed to support early career clinical and translational researchers.</p>","PeriodicalId":15529,"journal":{"name":"Journal of Clinical and Translational Science","volume":"9 1","pages":"e160"},"PeriodicalIF":2.0000,"publicationDate":"2025-08-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12392352/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical and Translational Science","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1017/cts.2024.673","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Over the last two decades, there have been significant investments designed to advance clinical and translational research (CTR) with an emphasis on supporting early career investigators and building a cadre of skilled researchers. Despite the investments, there are no comprehensive measurement tools to track individual-level progress along the research continuum as supports are put in place.

Objective: The Researcher Investment Tool (RIT) is a novel tool that was created to provide a consistent approach for measuring individual-level changes in the research career trajectory of investigators receiving support from CTR programs.

Methods: The RIT is a 90-item questionnaire, with eight domains and four sub-domains, designed to measure a researcher's experiences and perceptions. Several rounds of testing were conducted to assess the tool's face and content validity as well as the internal consistency and test-retest reliability.

Results: Psychometric testing revealed strong content validity and good internal consistency with Cronbach's alpha coefficients ranging from 0.85 to 0.97 across all domains. Test-retest reliability results also revealed stability in the domain measures over time with Pearson's correlation coefficients ranging from 0.70 to 0.98 for all but one domain (.53).

Conclusions: This novel RIT may be useful to evaluators when measuring the impact of investments designed to support early career clinical and translational researchers.

Abstract Image

Abstract Image

研究人员投资工具的开发、有效性和可靠性。
背景:在过去的二十年中,有大量的投资旨在推进临床和转化研究(CTR),重点是支持早期职业研究者和建立一支熟练的研究人员队伍。尽管有投资,但由于支持到位,没有全面的测量工具来跟踪研究连续体中个人层面的进展。研究人员投资工具(RIT)是一种新颖的工具,旨在提供一种一致的方法来衡量接受CTR计划支持的研究人员在研究生涯轨迹中的个人水平变化。方法:RIT是一份90题的问卷,有8个域和4个子域,旨在衡量研究人员的经验和看法。进行了多轮测试,以评估工具的外观和内容效度以及内部一致性和重测信度。结果:心理测量结果显示,各领域的内容效度较强,内部一致性较好,Cronbach's alpha系数在0.85 ~ 0.97之间。测试-重测信度结果还显示,随着时间的推移,领域测量的稳定性与Pearson相关系数范围从0.70到0.98,除了一个领域(0.53)。结论:这种新颖的RIT可能对评估人员在衡量旨在支持早期职业临床和转化研究人员的投资影响时有用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Clinical and Translational Science
Journal of Clinical and Translational Science MEDICINE, RESEARCH & EXPERIMENTAL-
CiteScore
2.80
自引率
26.90%
发文量
437
审稿时长
18 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信